In a report published Friday, Barrington reiterated its Outperform rating and $650.00 price target on Intuitive Surgical ISRG.
Barrington noted, “We are reiterating our OUTPERFORM rating and $650 price target following ISRG's Q4/12 earnings as we believe management will continue to execute on its significant market opportunities over the short and long term and will drive strong procedure growth/pricing power with new technologies in new procedures. We believe the short reports circulated recently are largely based on unfounded concerns and we expect the patient and hospital demand for da Vinci procedures to remain high in the face of the issues highlighted in those reports.”
Intuitive Surgical closed on Thursday at $576.07.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in